When was Insulet founded?

Insulet was founded in 2000 and raised its 1st funding round within a year of its incorporation.

Where is Insulet located?

Insulet is headquartered in Boston, United States. It is registered at Acton, Massachusetts.

How many employees does Insulet have?

As of Sep 30, 2026, the latest employee count at Insulet is 5485.

Is Insulet a funded company?

Insulet is a funded company, having raised a total of $120M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2000.

When was the latest funding round of Insulet?

Insulet's latest funding was a $***** Post IPO round on Jun 03, 2014, with participation from 0 investor.

What is the annual revenue of Insulet?

Annual revenue of Insulet is more than $1B as on Dec 31, 2025

Where does Insulet rank among its competitors?

Insulet ranks 3rd amongst 444 active competitors, of which 109 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Signos, which secured $20M in May, 2026.

Who are the top competitors of Insulet?

Insulet's top competitors include Dexcom, Tandem Diabetes and Senseonics. Among them, Signos secured the most recent funding round in May, 2026.

Insulet - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Manufacturer of wearable, tubeless insulin delivery systems for diabetes management. The company develops and provides simple, connected devices for continuous insulin delivery. These devices offer an alternative to multiple daily injections. The company focuses on research and development to improve its technologies.

Website: www.insulet.com/
Phone Number: +1 **********
Registered Address: Acton, Massachusetts

Key Metrics

Founded Year

2000

Location

Boston, United States

Stage

Public

Total Funding

$120M in 8 rounds

Latest Funding Round

Post IPO, Jun 03, 2014, $*****

Investors

Piper Jaffray & 14 more

Ranked

3^rd among 444 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

5,485 as on Sep 30, 2026

Investment & Acquisitions

Glooko & 1 more

Similar Companies

Dexcom & 520 more

Exit Details

Public

View Insulet's full profile

Insulet is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Insulet Corporation CIN: 91582297 , United States, Active	Feb 15, 2013	-	-	-
INSULET CORP CIN: 1145197 , United States, Active	Jul 19, 2000	$1B+ (As on Dec 31, 2025)	-	-
Insulet Corporation CIN: 43523891 , United States, Active	Dec 26, 999	-	2707 (As on Dec 31, 2024)	-

Insulet got listed on May 18, 2007.

Click here to take a look at Insulet's IPO in detail

Insulet has raised a total funding of $120M over 8 rounds. Its first funding round was on 2000. Insulet has 15 institutional investors.

Here is the list of recent funding rounds of Insulet:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 03, 2014	1826534	Post IPO	2614622	8664940	9011922	5258104
Mar 16, 2009	2208439	Venture Debt	6472177	6844455	6620676	Deerfield
Jan 19, 2007	8053804	Series E	9780723	9121710	7522010	5986094

Access funding benchmarks and valuations. Sign up today!

View details of Insulet's funding rounds and investors

Insulet's employee count trend

Insulet has 5,485 employees as of Sep 26. Here is Insulet's employee count trend over the years:

Uncover Insulet's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Insulet include Dexcom, Tandem Diabetes and Senseonics. Here is the list of Top 10 competitors of Insulet, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dexcom 1999, San Diego (United States), Public	Provider of a wearable device for glucose monitoring	$52.7M	Invesco Mutual Fund, Canaan & 7 others	79/100
2nd	Tandem Diabetes 2008, San Diego (United States), Public	Developer of devices for continuous glucose monitoring and manual insulin delivery	$101M	Gynther Capital, Domain Associates & 5 others	77/100
3rd	Insulet 2000, Boston (United States), Public	Manufacturer of wearable, tubeless insulin delivery systems for diabetes management	$120M	Piper Jaffray, Versant Ventures & 13 others	74/100
4th	Senseonics 1996, Germantown (United States), Public	Provider of implantable systems for continuous glucose monitoring	$165M	Greenspring Associates, Vensana Capital & 9 others	71/100
5th	Signos 2020, San Francisco (United States), Series B	Provider of a wearable device for blood glucose pattern monitoring	$57M	Google Ventures, Cheyenne Ventures & 14 others	71/100
6th	mySugr 2012, Vienna (Austria), Acquired	Gamification apps for diabetes management and therapy	$4.8M	iSeed Ventures, Roche & 7 others	70/100
7th	Ceribell 2014, Mountain View (United States), Public	EEG system for the diagnosis of seizures	$188M	The Rise Fund, Longitude Capital & 11 others	69/100
8th	Livongo 2014, San Francisco (United States), Acquired	Provider of smart devices for diabetes management for patients and doctors	$245M	General Catalyst, Kinnevik & 21 others	69/100
9th	HyperIce 2011, Irvine (United States), Series C	Internet first brand offering smart devices for physical fitness	$52.5M	MainStreet Advisors, SC.Holdings & 38 others	69/100
10th	sugar.fit 2021, Bengaluru (India), Series A	Provider of diabetes care and reversal programs	$26.7M	B Capital, MassMutual Ventures & 16 others	68/100